Noscendo GmbH is a leading global provider of software-based pathogen identification technology. Their objective is to revolutionize infection diagnostics and save patient lives. Noscendo's flagship product, DISQVER, is an innovative analysis platform that is already being used by numerous university hospitals, regional hospitals, hospital groups, and health insurance providers.

The company has received several awards for their pioneering approach, including the Health-i Pioneer 2020 award and the SIK Innovation Prize 2019. Noscendo is committed to advancing the field of healthcare and improving patient outcomes. They have a dedicated team of experts, including medical project managers, data engineers, bioinformaticians, and customer success agents.

Noscendo's Advisory Board consists of renowned professionals in the field, including esteemed scientists and biochemists. With their cutting-edge technology and exceptional team, Noscendo is at the forefront of revolutionizing infection diagnostics and improving patient care. Visit their website to learn more about their products, team, and latest news